Romofab Holding ApS: Financial statements 2025
CVR: 38556797
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Romofab Holding ApS (CVR 38556797) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -13,750 and a net result of DKK 284,766 compared with DKK -2,029,900 the year before. Equity in the 2025 report amounted to DKK -1,399,345.
- Gross Profit
- DKK -13,750
- Profit/Loss
- DKK 284,766
- Equity
- DKK -1,399,345
- Total Assets
- DKK 165,885
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -14 t. | 285 t. | -1.4 mio. | 0 |
| 2024 | - | 0 | -2 mio. | -1.7 mio. | 0 |
| 2023 | - | -13 t. | -42 t. | 346 t. | 0 |
| 2022 | - | -13 t. | -29 t. | 388 t. | 0 |
| 2021 | - | -16 t. | -18 t. | 417 t. | 0 |
Official annual report
How creditworthy is Romofab Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Romofab Holding ApS has published its annual report for 2024. Gross profit came to DKK 0, and the net result was DKK -2,029,900.
About Romofab Holding ApS
Romofab Holding ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Molly Bilde Fabrin and Robert Fabrin. The company is owned by Robert Fabrin and Molly Bilde Fabrin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -13,750 and a net result of DKK 284,766 compared with DKK -2,029,900 the year before. Equity in the 2025 report amounted to DKK -1,399,345.